awmsg logo



fentanyl citrate (Breakyl®)


Reference No. 1177

Publication date:
13/10/2011


Appraisal information

fentanyl citrate (Breakyl®) buccal film


Company: Meda Pharmaceuticals Ltd
BNF category: Central nervous system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 11/10/2011

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, fentanyl citrate (Breakyl®) cannot be endorsed for use within NHS Wales for the management of breakthrough pain in opioid tolerant adult patients with cancer.
Statement of Advice (SOA)
Download